The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.01
Bid: 1.84
Ask: 1.96
Change: -0.14 (-6.86%)
Spread: 0.12 (6.522%)
Open: 2.00
High: 2.01
Low: 2.00
Prev. Close: 2.04
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Mon, 21st Jun 2021 16:11

Tuesday 22 June 
Caerus Mineral Resources PLCAGM
Coca-Cola HBC AGAGM
Cora Gold LtdAGM
EPE Special Opportunities LtdAGM
Frenkel Topping Group PLCAGM
Intelligent Ultrasound Group PLCAGM
RTW Venture Fund LtdAGM
Surgical Innovations Group PLCAGM
Urban Exposure PLCGM re cancellation from AIM, liquidation
Wednesday 23 June 
Angling Direct PLCAGM
Clontarf Energy PLCAGM
Dignity PLCAGM - dispute with Phoenix UK Fund, which wants to replace chair
Directa Plus PLCAGM
ECSC Group PLCAGM
Harbour Energy PLCAGM
Incanthera PLCAGM
IQE PLCAGM
JKX Oil & Gas PLCAGM
LSL Property Services PLCAGM
Oriole Resources PLCAGM
Pebble Beach Systems Group PLCAGM
PetroTal CorpAGM
Premier Oil PLCAGM
Touchstar PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Woodbois LtdAGM
Thursday 24 June 
Argo Blockchain PLCAGM
Atalaya Mining PLCAGM
Boston International Holdings PLCGM
Fresnillo PLCAGM
Gemfields Group LtdAGM
Incanthera PLCAGM
Itaconix PLCAGM
Kavango Resources PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Science in Sport PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serica Energy PLCAGM
STM Group PLCAGM
Tandem Group PLCAGM
THG PLCAGM
Westminster Group PLCAGM
Friday 25 June 
Cadogan Petroleum PLCAGM
Entain PLCAGM
Gulf Marine Services PLCGM re share placing
HeiQ PLCAGM
Hemogenyx Pharmaceuticals PLCAGM
Inspiration Healthcare Group PLCAGM
Norman Broadbent PLCAGM
SDX Energy PLCAGM
Serabi Gold PLCAGM
Tesco PLCAGM
Tiziana Life Sciences PLCAGM
Monday 28 June 
Anglo-Eastern Plantations PLCAGM
Avacta Group PLCAGM
City Pub Group PLCAGM
Escape Hunt PLCAGM
Eurasia Mining PLCAGM
Futura Medical PLCAGM
Gulf Marine Services PLCAGM
Hiscox LtdEGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
ImmuPharma PLCAGM
Kanabo Group PLCAGM
Longboat Energy PLCGM re reverse takeover
Pennon Group PLCGM re share consolidation & changes to AoA
Symphony Environment Technologies PLCAGM
Volvere PLCAGM
Zinnwald Lithium PLCAGM
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Mar 2019 10:41

ImmuPharma Preparing For Lupuzor Drug Managed Access Programme

LONDON (Alliance News) - ImmuPharma PLC said it is in final preparations to open a managed access programme for its lupus drug Lupuzor to patients in Europe.Shares in the drug discovery and

Read more
26 Feb 2019 12:06

ImmuPharma upbeat on product from subsidiary Ureka

(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced on Tuesday that on 25 February, the peer reviewed research journal Nature Communications published a fundamental scientific publication on the proprietary technology 'Urelix' from its subsidiary Ureka.

Read more
31 Dec 2018 12:00

ImmuPharma and Incanthera extend exclusivity period for Nucant agreement

(Sharecast News) - Specialist drug discovery and development company ImmuPharma updated the market on its clinical development collaboration agreement for its 'Nucant' cancer programme on Monday, with specialist oncology development partner Incanthera.

Read more
7 Dec 2018 11:26

ImmuPharma Progressing To Make Lupuzor Available To Patients

LONDON (Alliance News) - ImmuPharma PLC on Friday said it is currently in the process of making Lupuzor, its drug for the treatment of lupus, available to patients via its managed access drug said

Read more
7 Dec 2018 08:09

Immupharma plots patient recruitment for Lupzor trials

(Sharecast News) - Drug discovery and development outfit Immupharma has progressed its managed access programme on Lupzor as planned, with patient recruitment in France and the UK expected to follow the firm's analysis of regulatory processes across the EU.

Read more
26 Sep 2018 13:55

ImmuPharma still banking on Lupuzor even after failed trial

(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced its interim results for the six months ended 30 June on Wednesday - a period in which its revenue remained negligible at £0.07m, but its drug candidate 'Lupuzor' demonstrated a superior response rate over placebo in its primary analysis on the full set of 202 patients.

Read more
26 Sep 2018 12:53

Wednesday broker round-up

(Sharecast News) - IAG: UBS downgrades to neutral with a target price of 705p.

Read more
26 Sep 2018 12:40

ImmuPharma Interim Loss Widens On Higher Costs And Lower Revenue

LONDON (Alliance News) - ImmuPharma PLC said on Wednesday it continues to progress its lupus treatment Lupuzor, as it saw a widened loss for the first half of 2018 due to higher costs and lower a

Read more
9 Sep 2018 10:59

Sunday share tips: Immupharma, PCF Bank

(Sharecast News) - For the 'Inside the City' column in the Sunday Times, Sabah Meddings wrote a "cautionary tale" about former biotech darling Immupharma, which last year saw its shares rise 227% over a year.

Read more
7 Sep 2018 11:43

ImmuPharma Inks Pact With Incanthera For Nucant Cancer Programme

LONDON (Alliance News) - ImmuPharma PLC said Friday it signed a clinical development collaboration for the Nucant cancer programme with Incanthera Ltd, a specialist oncology development the terms

Read more
7 Sep 2018 08:10

Immupharma to make 'blockbuster' lupus treatment available

(Sharecast News) - Pharmaceutical firm ImmuPharma on Friday signed an agreement for a managed access programme (MAP) for its "ground-breaking" new lupus treatment, Lupuzor.

Read more
14 Jun 2018 12:02

Immupharma Says P140 Peptide Shows Positive Results In CIDP Treatment

LONDON (Alliance News) - ImmuPharma PLC said Thursday that its pre-clinical studies of the P140 peptide showed positive results in the treatment of chronic inflammatory demyelinating were trading

Read more
29 May 2018 09:40

ImmuPharma Excited Despite Widened Loss As Lupuzor Makes Good Results

LONDON (Alliance News) - ImmuPharma PLC said Tuesday it continues to be "excited" by its future potential despite a widened loss for 2017.The drug development company reported a a

Read more
23 Mar 2018 11:17

ImmuPharma Prepares To Report Lupuzor Study Results In April

LONDON (Alliance News) - Drug development company ImmuPharma PLC said on Friday it has been informed by Simbec-Orion that the data-base lock for the Lupuzor pivotal phase III

Read more
25 Jan 2017 14:33

ImmuPharma trial of Lupuzor continuing smoothly

(ShareCast News) - Specialist drug discovery and development company ImmuPharma provided further details of patient participation on Wednesday, following confirmation in December that the company had successfully completed patient recruitment into its pivotal 52-week Phase III clinical trial of Lupu

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.